BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 34529707)

  • 1. GED-0507 attenuates lung fibrosis by counteracting myofibroblast transdifferentiation in vivo and in vitro.
    Speca S; Dubuquoy C; Rousseaux C; Chavatte P; Desreumaux P; Spagnolo P
    PLoS One; 2021; 16(9):e0257281. PubMed ID: 34529707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of glycogen synthase kinase-3β and PPAR-γ on epithelial-to-mesenchymal transition in DSS-induced colorectal fibrosis.
    Di Gregorio J; Sferra R; Speca S; Vetuschi A; Dubuquoy C; Desreumaux P; Pompili S; Cristiano L; Gaudio E; Flati V; Latella G
    PLoS One; 2017; 12(2):e0171093. PubMed ID: 28207769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel PPARγ Modulator GED-0507-34 Levo Ameliorates Inflammation-driven Intestinal Fibrosis.
    Speca S; Rousseaux C; Dubuquoy C; Rieder F; Vetuschi A; Sferra R; Giusti I; Bertin B; Dubuquoy L; Gaudio E; Desreumaux P; Latella G
    Inflamm Bowel Dis; 2016 Feb; 22(2):279-92. PubMed ID: 26535766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
    BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-β-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts.
    Omori K; Hattori N; Senoo T; Takayama Y; Masuda T; Nakashima T; Iwamoto H; Fujitaka K; Hamada H; Kohno N
    PLoS One; 2016; 11(2):e0148969. PubMed ID: 26859294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mimosa pudica L. extract ameliorates pulmonary fibrosis via modulation of MAPK signaling pathways and FOXO3 stabilization.
    Nguyen QC; Nguyen HA; Pham TA; Tran VT; Nguyen TD; Pham DV
    J Ethnopharmacol; 2024 Aug; 330():118226. PubMed ID: 38670401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of pulmonary fibrosis in type I collagen-targeted reporter mice with ALK-5 inhibitors.
    Terashima H; Aonuma M; Tsuchida H; Sugimoto K; Yokoyama M; Kato M
    Pulm Pharmacol Ther; 2019 Feb; 54():31-38. PubMed ID: 30448291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
    Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
    Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis.
    Milam JE; Keshamouni VG; Phan SH; Hu B; Gangireddy SR; Hogaboam CM; Standiford TJ; Thannickal VJ; Reddy RC
    Am J Physiol Lung Cell Mol Physiol; 2008 May; 294(5):L891-901. PubMed ID: 18162602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
    Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G
    Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
    Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
    J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis.
    Mou F; Mou C
    Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
    Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL
    Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway.
    Li LF; Kao KC; Liu YY; Lin CW; Chen NH; Lee CS; Wang CW; Yang CT
    J Cell Mol Med; 2017 Nov; 21(11):2937-2949. PubMed ID: 28598023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
    Wollin L; Maillet I; Quesniaux V; Holweg A; Ryffel B
    J Pharmacol Exp Ther; 2014 May; 349(2):209-20. PubMed ID: 24556663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
    Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
    Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
    J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversion of in vivo fibrogenesis by novel chromone scaffolds.
    Kim HS; Yoon YM; Meang MK; Park YE; Lee JY; Lee TH; Lee JE; Kim IH; Youn BS
    EBioMedicine; 2019 Jan; 39():484-496. PubMed ID: 30611717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitrated fatty acids reverse pulmonary fibrosis by dedifferentiating myofibroblasts and promoting collagen uptake by alveolar macrophages.
    Reddy AT; Lakshmi SP; Zhang Y; Reddy RC
    FASEB J; 2014 Dec; 28(12):5299-310. PubMed ID: 25252739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myricetin ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β signaling via targeting HSP90β.
    Li X; Yu H; Liang L; Bi Z; Wang Y; Gao S; Wang M; Li H; Miao Y; Deng R; Ma L; Luan J; Li S; Liu M; Lin J; Zhou H; Yang C
    Biochem Pharmacol; 2020 Aug; 178():114097. PubMed ID: 32535102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.